0001225208-15-005733.txt : 20150225 0001225208-15-005733.hdr.sgml : 20150225 20150225161033 ACCESSION NUMBER: 0001225208-15-005733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150223 FILED AS OF DATE: 20150225 DATE AS OF CHANGE: 20150225 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brennan Daniel J. CENTRAL INDEX KEY: 0001595612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 15647935 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2015-02-23 0000885725 BOSTON SCIENTIFIC CORP BSX 0001595612 Brennan Daniel J. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP and CFO Common Stock 2015-02-23 4 A 0 20442.0000 0.0000 A 129352.0000 D Common Stock 2015-02-23 4 F 0 6644.0000 16.3100 D 122708.0000 D Deferred Stock Units 2015-02-23 4 A 0 26824.0000 0.0000 A 2020-02-23 Common Stock 26824.0000 26824.0000 D Performance Share Units 2015-02-23 4 A 0 29185.0000 0.0000 A 2016-12-31 2016-12-31 Common Stock 29185.0000 29185.0000 D Stock Option (Right to Buy) 16.3100 2015-02-23 4 A 0 75431.0000 0.0000 A 2025-02-23 Common Stock 75431.0000 75431.0000 D On February 27, 2012, the reporting person was awarded a target number of performance share units under the Company's 2012 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2014 and was subject to the completion of the concurrent three-year individual service period. On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2016. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. /s/ Lee G. Giguere, Attorney-in-Fact 2015-02-25